Thorac Cardiovasc Surg 2014; 62(07): 554-560
DOI: 10.1055/s-0034-1376403
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Increased Content of Resistin in Epicardial Adipose Tissue of Patients with Advanced Coronary Atherosclerosis and History of Myocardial Infarction

Maciej Rachwalik
1   Department of Cardiac Surgery, Wrocław Medical University, Wrocław, Poland
,
Dorota Zyśko
2   Teaching Department for Emergency Medical Services, Wrocław Medical University, Wrocław Poland
,
Dorota Diakowska
3   Department and Clinic of Gastrointestinal and General Surgery, Wrocław Medical University, Wrocław, Poland
,
Wojciech Kustrzycki
1   Department of Cardiac Surgery, Wrocław Medical University, Wrocław, Poland
› Author Affiliations
Further Information

Publication History

17 December 2013

02 April 2014

Publication Date:
29 May 2014 (online)

Abstract

Objectives The aim of the study was to assess whether the plasma level and content of adipokines, in adipose tissue, is associated with a medical history of myocardial infarction.

Patients and Methods The study group consisted of 33 consecutive patients (12 females, 21 males, aged 68.6 ± 6.8 years) who underwent cardiac bypass surgery. Patients were divided into groups; group 1 presented with a history of myocardial infarction and group 2 presented without a history of myocardial infarction. During cardiac surgery, samples of epicardial adipose tissue, adipose tissue located at internal mammary artery, subcutaneous adipose tissue, and blood samples were taken for further assessment.

Significantly higher levels of resistin in adipose tissue from the epicardial tissue were found in group 1 than in group 2: median and interquartile range, respectively, 37.2 (8.9–121.5) ng/g versus 15.0 (7.1–24.1) ng/g; p < 0.049. Multivariate analysis found that previous myocardial infarction was associated with male gender, older age, and higher content of resistin in epicardial adipose tissue.

Conclusion The resistin content in epicardial adipose tissue in patients with advanced coronary atherosclerosis seems higher in those with a history myocardial infarction. Increased resistin epicardial content seems related to the previous myocardial infarction independent of the other established risk factors such as age and male gender. The importance of paracrine function of adipose pericardial tissue in the occurrence of complications of atherosclerosis merits further investigations.

 
  • References

  • 1 Hamm CW, Bassand JP, Agewall S , et al; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32 (23) 2999-3054
  • 2 Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2 (10) 536-543
  • 3 Baker AR, Silva NF, Quinn DW , et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1-7
  • 4 Mazurek T, Zhang L, Zalewski A , et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108 (20) 2460-2466
  • 5 Korah TE, Ibrahim HH, Badr EA, ElShafie MK. Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad Med J 2011; 87 (1029) 463-467
  • 6 Lubos E, Messow CM, Schnabel R , et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 2007; 193 (1) 121-128
  • 7 Li L, Han JL, Mao JM, Guo LJ, Gao W. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention. Chin Med J (Engl) 2013; 126 (6) 1058-1062
  • 8 Chu S, Ding W, Li K, Pang Y, Tang C. Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J 2008; 72 (8) 1249-1253
  • 9 Qiao XZ, Yang YM, Xu ZR, Yang LA. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris. J Zhejiang Univ Sci B 2007; 8 (12) 875-880
  • 10 Breiman L, Friedman JH, Olshen RA , et al. Classification and Regression Trees. Belmont, CA: Wadsworth International Group; 1984
  • 11 Rudnicki J, Zyśko D, Kozłowski D , et al. The choice of surgical specialization by medical students and their syncopal history. PLoS ONE 2013; 8 (1) e55236
  • 12 StatSoft Electronic Statistics Textbook . Available at: http://www.statsoft.com/textbook/classification-and-regression-trees/
  • 13 Steppan CM, Bailey ST, Bhat S , et al. The hormone resistin links obesity to diabetes. Nature 2001; 409 (6818) 307-312
  • 14 Ohmori R, Momiyama Y, Kato R , et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46 (2) 379-380
  • 15 Xu A, Wang Y, Lam KS, Vanhoutte PM. Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 2010; 60: 229-255
  • 16 Henrichot E, Juge-Aubry CE, Pernin A , et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler Thromb Vasc Biol 2005; 25 (12) 2594-2599
  • 17 Sahin-Efe A, Katsikeris F, Mantzoros CS. Advances in adipokines. Metabolism 2012; 61 (12) 1659-1665
  • 18 Lee SE, Kim HS. Human resistin in cardiovascular disease. J Smooth Muscle Res 2012; 48 (1) 27-35
  • 19 Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138 (5, Pt 2) S419-S420
  • 20 Gan AM, Butoi ED, Manea A , et al. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways. Cell Tissue Res 2013; 351 (1) 161-174
  • 21 Chuang TY, Au LC, Wang LC, Ho LT, Yang DM, Juan CC. Potential effect of resistin on the ET-1-increased reactions of blood pressure in rats and Ca2+ signaling in vascular smooth muscle cells. J Cell Physiol 2012; 227 (4) 1610-1618
  • 22 Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg 2005; 41 (4) 691-698
  • 23 Yaseen F, Jaleel A, Aftab J, Zuberi A, Alam E. Circulating levels of resistin, IL-6 and lipid profile in elderly patients with ischemic heart disease with and without diabetes. Biomarkers Med 2012; 6 (1) 97-102
  • 24 Wang H, Chen DY, Cao J, He ZY, Zhu BP, Long M. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J 2009; 24 (3) 161-166
  • 25 Hu WL, Qiao SB, Hou Q, Yuan JS. Plasma resistin is increased in patients with unstable angina. Chin Med J (Engl) 2007; 120 (10) 871-875
  • 26 Luc G, Empana JP, Morange P , et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond) 2010; 34 (1) 118-126
  • 27 Langheim S, Dreas L, Veschini L , et al. Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol 2010; 298 (3) H746-H753
  • 28 Thanassoulis G, Massaro JM, Corsini E , et al. Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc 2012; 1 (6) e000885
  • 29 Kremen J, Dolinkova M, Krajickova J , et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91 (11) 4620-4627
  • 30 Cheng JM, Akkerhuis KM, Battes LC , et al. Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur J Heart Fail 2013; 15 (12) 1350-1362